APNA 26th Annual Conference Session 2012: November 8, 2012

Size: px
Start display at page:

Download "APNA 26th Annual Conference Session 2012: November 8, 2012"

Transcription

1 From Circuits to Solutions: Brain Function in Pediatric Bipolar and Attention Deficit Disorders Julie A Carbray PhD, APN, BC Clinical Professor Pediatric Brain Research and Intervention Center Institiute for Juvenile Research University of Illinois at Chicago Disclosure Financial Disclosure Shionogi Inc, This speaker has not other conflict of interest to disclose. Objectives Identify both common and differing brain circuitry dysfunction patterns implicated in Pediatric Bipolar Disorder and Attention Deficit Hyperactivity Disorder Discuss how brain circuitry dysfunction relates to symptoms and the clinical presentation of illness in children and adolescents affected by these disorders Integrate theoretical underpinnings of brain circuitry dysfunction into neurobiologically informed nursing care of children and adolescents affected by Pediatric Bipolar Disorder and Attention Deficit Hyperactivity Disorder _ Carbray 1

2 Research Domain Criteria (RDoC) Strategies Improving classification of psychopathology based on dimensions of behavior and neurobiological measures Study basic dimensions of functioning (e.g., affect, cognition) across multiple levels of analysis (e.g., genetic, circuits, behavior) Insel and Cuthbert, NIMH BIOSIGNATURE OF ACTIVITY STUDIES: HOW I USE THE MODEL TO EDUCATE FAMILIES Pavuluri and Sweeney, JAACAP, 2008 BRAIN FUNCTION: SIX DYNAMIC CIRCUITS Probing the Brain Functional Domains Feeling Circuit (Fronto-limbic circuit) Understanding Facial Emotions circuit (Face response circuit) Reactive Circuit (Occipito-limbic associative circuit) (Face response circuit) Inhibiting impulsive behavior circuit (Response Inhibition circuit) Thinking circuit (Cognitive Circuit) Interface of thinking and feeling circuit Carbray 2

3 Impulsivity, Executive Functions and Reward Systems Differentiate PBD and ADHD EXECUTIVE SYSTEMS REWARD/ AFFECTIVE SYSTEMS IMPULSIVITY Interface of Impulse Regulation, Affect And Reward Systems VENTRAL FRONTO- STRIATAL SYSTEM DORSAL FRONTO- STRIATAL SYSTEM +VLPFC has Dual Role Passarotti and Pavuluri, 2011 Cognitive and Emotional Impulsivity ADHD Fronto-striatal PBD Fronto-striatal DORSAL SYSTEM VENTRAL SYSTEM Affective/Motivation Systems Cognitively-Driven Impulsivity Affective/Motivation Systems Emotionally-Driven Impulsivity Carbray 3

4 Neurobiologically-informed Treatment vity Impulsi? Passarotti and Pavuluri, 2011 Different Response Inhibition Phenotypes in PBD and ADHD PBD - ADHD PBD - HC ADHD - HC Y=19 Y=45 Y=20 Correct Stop minus correct Go Trials Red indicates greater activation in the first group of the comparison than in the second group Blue indicates the opposite. R=right; L=left. Passarotti et al. 2010; Psychiatry Research Conclusions During response inhibition both PBD and ADHD patients show PFC dysfunction relative to HC This dysfunction is more focal in PBD (i.e., VLPFC) and more generalized (i.e., both VPFC and DLPFC) in ADHD When comparing the two patient groups, ADHD has more compromised inhibition function, with reduced activation both in DLPFC and VLPFC, relative to PBD Carbray 4

5 Angry vs. Neutral Faces PBD - ADHD PBD - HC ADHD - HC Y=20 Y=5 Y=32 15 PBD 19 HC Mean Age =13.36±2.65 Passarotti et al., 2010; JAACAP Conclusions PBD and ADHD patients, relative to HC, show corticosub-cortical activity that is reduced under negative emotional challenge PBD relative to ADHD exhibits greater deployment of the emotion processing circuitry and reduced deployment of cognitive/working memory circuit under negative emotional challenge. Reduced Functional Connectivity in Amygdala and VLPFC In the Affect Regulation and Evaluation Network in PBD VMPFC AMYDALA VLPFC 41 PBD 16 HC Mean Age =14.32±2.76 [AACAP POSTER # 5.31] Passarotti et al., under review Carbray 5

6 Pharmacotherapy Effects on VLPFC and Amygdala Function in PBD A B C PBD vs HC A) Angry Face condition at Baseline B) Happy Face condition at Baseline C) Angry Face condition at Follow-up vs. Baseline Amydala Passarotti et al., 2011 Reward Circuits in interaction with Affect and Impulse Regulation Circuits *Reward Related Functions Ventral Fronto-insularamygdalar Circuit *Affect Regulation Dimension Fronto-dorsal-striatal Ciruit *Impulse Regulation Dimension Delay Discounting Task 85 PBD 65 ADHD 100 HC Mean Age ± 2.2 Passarotti et al., (in preparation) Carbray 6

7 Response to Monetary Reward and Loss in PBD vs. ADHD PBD vs ADHD The ventral fronto-striatal circuit is differentially modulated by positive and negative contingencies in PBD and ADHD. PBD shows greater ventral striatum activity than ADHD and HC for losses Monetary Reward and Loss Task ADHD shows similar response for reward and loss. Stop Signal Task with Monetary Feedback We tested the ability to adjust performance on Stop signal task based on feedback contingencies PBD exhibited decreased dorsal fronto-striatal regulation relative to ADHD on incorrect stop trials with negative feedback PBD vs ADHD Affective Impulsivity: Frustration and affective over-reactivity lead to decreased dorsal frontostriatal engagement in PBD relative to ADHD Implications for Neurobiologically-informed informed Treatment Mood stabilizers to aid ventral frontostriatal and limbic system Stimulants to aid dorsal fronto striatal system Contingencybased Intervention: - Rainbow CFF-CBT -Working Memory Enhancement Carbray 7

8 Mood Stabilization Medication* Mood stabilizer Second Generation Antipsychotic First Choice Lithium Risperidone, Aripiprazole Sequence of Choices DVPX, CBZ, Lamotrigine, Topiramate Oxcarbazepine Quetiapine, Ziprasidone,, Olanzapine, *Any history of a drug that had negative or no effect was not prescribed; Combination of MS+SGA if severe Working Memory Enhancement Program Cogmed Computer-based Working Memory Training (Klingberg et al., 2005) Few of many books out there; We wrote with the mission of reaching out to parents and clinicians training in this field Carbray 8

9 Current Funding Sources NARSAD Young Investigator (AP) Colbeth Endowment Funds (MP) Marshall Reynolds (MP) NIH/NIMH (MP) 1R01MH081019A 1R01MH A1 RC1MH HHSN C The Pediatric Brain Research And Intervention Center Phone: (312) www/psych.uic.edu/brain-center The Pediatric Brain Research and Intervention Center Institute for Juvenile Research University of Illinois at Chicago Department of Psychiatry 1747 West Roosevelt Road Chicago, Illinois Pediatric BRAIN Center Mani N Pavuluri, MD, PhD Alessandra Passeroti PhD Minjie Wu PhD Lisa Lu PhD Jacklynn Fitzgerald BA James Ellis BA Hongyu Yang PhD Binu Varghese MA Richard Whitley MA Jon O Neil BA Allison Lowes BA Meredith Wong BA Stephanie Monroe BA Bryn Levitan BA Nicole Witowski BA Nathan Carley BA Noah Yulish MA Gail Schuck BA Jean Madigan BA Our Team MRI Methodology Joe Zhou PhD Deb Little PhD Genomics and Neurochemistry Jeff Bishop Pharm D Christian Gossett BA Ghan Shyam Pandey PhD Yogesh Dwivedi PhD Clinical Julie Carbray PhD Sonali Nanayakkara MD Amy West PhD Sally Weinstein PhD Collaborators Mike Stevens PhD John Sweeney PhD Mark Stein PhD Carbray 9

10 Carbray 10

Concept: Wiring Problems Can Explain the Clinical Presentation. Pediatric Psychopharmacology: Mood Disorders

Concept: Wiring Problems Can Explain the Clinical Presentation. Pediatric Psychopharmacology: Mood Disorders Pediatric Psychopharmacology: Mood Disorders Child Clinical Psychopharmacology Institute 2009 Julie Carbray PhD, APN, PMHCNS-BC Institute for Juvenile Research University of Illinois at Chicago CPI 2009

More information

October Dear Dr. Brambilla and Dr. Soares,

October Dear Dr. Brambilla and Dr. Soares, Mani N. Pavuluri, MD, PhD Director, Pediatric Mood Disorders Program Professor in Psychiatry Berger-Colbeth Chair in Child Psychiatry October 7 2015 Institute for Juvenile Research (MC 747) Westside Research

More information

Introduction. PMDC Team

Introduction. PMDC Team Best Practices for Outpatient Program in Bipolar Disorder: Pediatric Mood Disorders Program at the University of Illinois at Chicago Julie A. Carbray PhD, PMHN-CNS Introduction five fold increase in diagnosis

More information

JACKLYNN M. FITZGERALD

JACKLYNN M. FITZGERALD JACKLYNN M. FITZGERALD CURRICULUM VITAE CONTACT Jacklynn M. Fitzgerald, PhD University of Wisconsin - Milwaukee Department of Psychology 2441 E. Hartford Ave. Milwaukee, WI 53211 fitzgejm@uwm.edu EMPLOYMENT

More information

EARLY ONSET SCHIZOPHRENIA

EARLY ONSET SCHIZOPHRENIA Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences EARLY ONSET SCHIZOPHRENIA JON MCCLELLAN CHILD STUDY AND TREATMENT CENTER GENERAL DISCLOSURES The University of Washington

More information

Neuro-cognitive systems underpinning antisocial behavior and the impact of maltreatment and substance abuse on their development

Neuro-cognitive systems underpinning antisocial behavior and the impact of maltreatment and substance abuse on their development Neuro-cognitive systems underpinning antisocial behavior and the impact of maltreatment and substance abuse on their development R.J.R. Blair Center for Neurobehavioral Research 1 Talk plan Boys Town and

More information

Bipolar Disorder in Youth

Bipolar Disorder in Youth Bipolar Disorder in Youth Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric Bipolar Disorder Research Program Harvard Medical School Massachusetts General Hospital Pediatric-Onset

More information

9/13/2018. Neurobiological Aspects of Attention Deficit Hyperactivity Disorder (ADHD) DSM-5 Diagnostic Criteria

9/13/2018. Neurobiological Aspects of Attention Deficit Hyperactivity Disorder (ADHD) DSM-5 Diagnostic Criteria DSM-5 Diagnostic Criteria Neurobiological Aspects of Attention Deficit Hyperactivity Disorder (ADHD) Neil P. Jones 7th Annual Conference on ADHD and Executive Function September 14, 218 Diagnosis Child

More information

Mapping Neural circuitry of Risk and Resilience for Suicidal Behavior and Mood Disorders

Mapping Neural circuitry of Risk and Resilience for Suicidal Behavior and Mood Disorders Mapping Neural circuitry of Risk and Resilience for Suicidal Behavior and Mood Disorders J. John Mann, MD Paul Janssen Professor of Translational Neuroscience in Psychiatry and Radiology Columbia University

More information

Neuroscience-Based Formulation and Treatment for Early-Onset Bipolar Disorder: a Paradigm Shift

Neuroscience-Based Formulation and Treatment for Early-Onset Bipolar Disorder: a Paradigm Shift Curr Treat Options Psych (2015) 2:229 251 DOI 10.1007/s40501-015-0048-3 Mood Disorders (S Frangou, Section Editor) Neuroscience-Based Formulation and Treatment for Early-Onset Bipolar Disorder: a Paradigm

More information

EZRA WEGBREIT, PH.D.

EZRA WEGBREIT, PH.D. EZRA WEGBREIT, PH.D. 22 Sullivan St., Cazenovia, NY 13035 Phone: (315) 655-7306 Fax: (315) 655-2157 E-mail: ewegbreit@cazenovia.edu EDUCATION 08/05 - Ph.D., Psychology Brain, Behavior, and Cognition 12/10

More information

The Adolescent Developmental Stage

The Adolescent Developmental Stage The Adolescent Developmental Stage o Physical maturation o Drive for independence o Increased salience of social and peer interactions o Brain development o Inflection in risky behaviors including experimentation

More information

Fronto-limbic Dysfunction in Mania Pre-Treatment and Persistent Amygdala Overactivity

Fronto-limbic Dysfunction in Mania Pre-Treatment and Persistent Amygdala Overactivity Fronto-limbic Dysfunction in Mania Pre-Treatment and Persistent Amygdala Overactivity Post-Treatment in Pediatric Bipolar Disorder Alessandra M. Passarotti a-b*, John A. Sweeney b, Mani N. Pavuluri a-b

More information

Psych3BN3 Topic 4 Emotion. Bilateral amygdala pathology: Case of S.M. (fig 9.1) S.M. s ratings of emotional intensity of faces (fig 9.

Psych3BN3 Topic 4 Emotion. Bilateral amygdala pathology: Case of S.M. (fig 9.1) S.M. s ratings of emotional intensity of faces (fig 9. Psych3BN3 Topic 4 Emotion Readings: Gazzaniga Chapter 9 Bilateral amygdala pathology: Case of S.M. (fig 9.1) SM began experiencing seizures at age 20 CT, MRI revealed amygdala atrophy, result of genetic

More information

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral

More information

Chronic irritability in youth that may be misdiagnosed as bipolar disorder. Ellen Leibenluft, M.D.

Chronic irritability in youth that may be misdiagnosed as bipolar disorder. Ellen Leibenluft, M.D. Chronic irritability in youth that may be misdiagnosed as bipolar disorder Ellen Leibenluft, M.D. Chief, Section on Bipolar Spectrum Disorders Emotion and Development Branch National Institute of Mental

More information

Amygdala Functional Connectivity Predicts Pharmacotherapy Outcome in Pediatric Bipolar Disorder

Amygdala Functional Connectivity Predicts Pharmacotherapy Outcome in Pediatric Bipolar Disorder BRAIN CONNECTIVITY Volume 1, Number 5, 2011 ª Mary Ann Liebert, Inc. DOI: 10.1089/brain.2011.0035 Amygdala Functional Connectivity Predicts Pharmacotherapy Outcome in Pediatric Bipolar Disorder Ezra Wegbreit,

More information

Altered affective, executive and sensorimotor resting state networks in patients with pediatric mania

Altered affective, executive and sensorimotor resting state networks in patients with pediatric mania Research Paper Altered affective, executive and sensorimotor resting state networks in patients with pediatric mania Minjie Wu, PhD; Lisa H. Lu, PhD; Alessandra M. Passarotti, PhD; Ezra Wegbreit, PhD;

More information

FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality

FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality FL Medicaid Drug Therapy Management Program for Behavioral Health Monitoring for Safety and Quality April 23, 2014 Pensacola, FL Presentation Objectives To briefly describe the program and how its components

More information

Reviews and Overviews. Mechanisms of Psychiatric Illness

Reviews and Overviews. Mechanisms of Psychiatric Illness Reviews and Overviews Mechanisms of Psychiatric Illness A Critical Appraisal of Neuroimaging Studies of Bipolar Disorder: Toward a New Conceptualization of Underlying Neural Circuitry and a Road Map for

More information

PEER REVIEWED PUBLICATIONS IN INTERNATIONAL JOURNALS

PEER REVIEWED PUBLICATIONS IN INTERNATIONAL JOURNALS PEER REVIEWED PUBLICATIONS IN INTERNATIONAL JOURNALS 1. Cardenas A, Villavicencio L, Pavuluri M. Considerations in the neuropsychological evaluation and treatment of children with limited English proficiency.

More information

Aggression (Severe) in Children under Age 6

Aggression (Severe) in Children under Age 6 Aggression (Severe) in Children under Age 6 Level 0 Comprehensive diagnostic assessments. Refer to Principles of Practice on page 6. Evaluate and treat comorbid conditions (i.e. medical, other psychiatric

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,

More information

Biological Risk Factors

Biological Risk Factors Biological Risk Factors Ms Angelina Crea Provisional Psychologist Academic Child Psychiatry Unit Royal Children s Hospital Professor Alasdair Vance Head Academic Child Psychiatry Department of Paediatrics

More information

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder,

Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Practice Parameter for the Assessment and Treatment of Children and Adolescents with Bipolar Disorder, Journal of the Academy of Child and Adolescent Psychiatry, 1997 Primary Authors: Jon McClellan MD

More information

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic

More information

A systematic review of adolescent physiological development and its relationship with health-related behaviour

A systematic review of adolescent physiological development and its relationship with health-related behaviour A systematic review of adolescent physiological development and its relationship with health-related behaviour This resource may also be made available on request in the following formats: 0131 314 5300

More information

Cognitive and neural basis of emotion regulation in bipolar disorder

Cognitive and neural basis of emotion regulation in bipolar disorder Cognitive and neural basis of emotion regulation in bipolar disorder Psychiatry Associate Professor Melissa Green, PhD. NHMRC Biomedical Career Development Fellow School of Psychiatry, Faculty of Medicine

More information

Attention-deficit/hyperactivity disorder (ADHD) is characterized

Attention-deficit/hyperactivity disorder (ADHD) is characterized REVIEW Cool Inferior Frontostriatal Dysfunction in Attention-Deficit/Hyperactivity Disorder Versus Hot Ventromedial Orbitofrontal-Limbic Dysfunction in Conduct Disorder: A Review Katya Rubia Attention-deficit/hyperactivity

More information

Neuroeconomics in the Clinic and Courtroom. Michael Koenigs, PhD Associate Professor Department of Psychiatry University of Wisconsin-Madison

Neuroeconomics in the Clinic and Courtroom. Michael Koenigs, PhD Associate Professor Department of Psychiatry University of Wisconsin-Madison Neuroeconomics in the Clinic and Courtroom Michael Koenigs, PhD Associate Professor Department of Psychiatry University of Wisconsin-Madison Outline Overview of brain regions Applications in psychiatry

More information

D I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment.

D I A G N O S I S ADD/ADHD. Conduct Disorder. Oppositional. Oppositional Defiant Disorder. Defiant. Anxiety Disorder. Adjustment. Dr. Crismon has no potential conflicts of interest to disclose with regard to this presentation. M. Lynn Crismon, Pharm.D., FCCP, BCPP Dean James T. Doluisio Regents Chair & Behrens Centennial Professor

More information

Systematic review of the neural basis of social cognition in patients with mood disorders

Systematic review of the neural basis of social cognition in patients with mood disorders Review Paper Systematic review of the neural basis of social cognition in patients with mood disorders Andrée M. Cusi, BSc; Anthony Nazarov, BSc; Katherine Holshausen, BSc; Glenda M. MacQueen, MD, PhD;

More information

Things You Might Not Know About Psychotropic Medications But Wish You Did

Things You Might Not Know About Psychotropic Medications But Wish You Did Things You Might Not Know About Psychotropic Medications But Wish You Did John E. Dunne, MD December 3, 2016 PAL Conference Conflicts of Interest None to report I am employed by Seattle Children s and

More information

Deficits in Emotional Regulation in ADHD

Deficits in Emotional Regulation in ADHD Deficits in Emotional Regulation in ADHD Joseph Biederman, MD Professor of Psychiatry Harvard Medical School Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD Massachusetts

More information

Research Domain Criteria: What They Are and Why They Matter Stephen J. Glatt, Ph.D. Stephen V. Faraone, Ph.D.

Research Domain Criteria: What They Are and Why They Matter Stephen J. Glatt, Ph.D. Stephen V. Faraone, Ph.D. Research Domain Criteria: What They Are and Why They Matter Stephen J. Glatt, Ph.D. Stephen V. Faraone, Ph.D. Department of Psychiatry and Behavioral Sciences, Department of Neuroscience and Physiology,

More information

Outpatient use of Atypical Antipsychotic Agents in the Pediatric Population Years

Outpatient use of Atypical Antipsychotic Agents in the Pediatric Population Years Outpatient use of Atypical Antipsychotic Agents in the Pediatric Population Years 2004-2008 Laura Governale, Pharm.D., MBA Team Leader, Drug Utilization Data Analyst Hina Mehta, Pharm.D. Drug Utilization

More information

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release

More information

Medication Management in Tic Disorders. Erica Greenberg, MD Pediatric Psychiatry OCD and Tic Disorders Program 7/29/18

Medication Management in Tic Disorders. Erica Greenberg, MD Pediatric Psychiatry OCD and Tic Disorders Program 7/29/18 Medication Management in Tic Disorders Erica Greenberg, MD Pediatric Psychiatry OCD and Tic Disorders Program 7/29/18 Speaker Disclosures: No relevant disclosures (Clinical research study funded in part

More information

Post Traumatic Stress Disorder (PTSD) versus Bipolar Disorder: Confusion in the face of chaos.

Post Traumatic Stress Disorder (PTSD) versus Bipolar Disorder: Confusion in the face of chaos. Post Traumatic Stress Disorder (PTSD) versus Bipolar Disorder: Confusion in the face of chaos. Randall Ricardi D.O. Child and Adolescent Psychiatry Phoenix Children s Hospital 6-24-17 10:50am Disclosures

More information

Research Domain Criteria (RDoC): Toward Future Psychiatric Diagnosis

Research Domain Criteria (RDoC): Toward Future Psychiatric Diagnosis Research Domain Criteria (RDoC): Toward Future Psychiatric Diagnosis Norwegian Psychiatric Association Bruce N. Cuthbert, Ph. D. Acting Director National Institute of Mental Health 10 March 2015 NIMH RDoC

More information

PTSD and the brain: What clinicians need to know

PTSD and the brain: What clinicians need to know PTSD and the brain: What clinicians need to know Namik Kirlić, MA Elana Newman, PhD Underexplored Territories in Trauma Education: Charting Frontiers for Clinicians and Researchers The University of Tulsa

More information

Understanding and Treating Behavioral Addictions

Understanding and Treating Behavioral Addictions Understanding and Treating Behavioral Addictions Jon Grant, MD, JD, MPH Professor of Psychiatry and Behavioral Neuroscience University of Chicago Chicago, Illinois Disclosure The faculty have been informed

More information

IMPACT OF TRAUMA ON CHILDHOOD DEVELOPMENT

IMPACT OF TRAUMA ON CHILDHOOD DEVELOPMENT IMPACT OF TRAUMA ON CHILDHOOD DEVELOPMENT IMPLICATIONS FOR THE EDUCATION AND SOCIAL PROWESS OF REFUGEE CHILDREN C. Richard Clark BA (Hons), PhD, MACS, BCN, FANSA, FASSA Emeritus Professor, Flinders University,

More information

Dr. Alan Carroll MB, BCh, MRC Psych. FRCP(C) Psychiatrist, Clinical Professor of Psychiatry, University of Alberta Glenrose Rehabilitation Hospital

Dr. Alan Carroll MB, BCh, MRC Psych. FRCP(C) Psychiatrist, Clinical Professor of Psychiatry, University of Alberta Glenrose Rehabilitation Hospital Dr. Alan Carroll MB, BCh, MRC Psych. FRCP(C) Psychiatrist, Clinical Professor of Psychiatry, University of Alberta Glenrose Rehabilitation Hospital Introduction! Tics Description and Variation! Tourette

More information

Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives

Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives Promoting and Monitoring Evidenced-Based Antipsychotic Prescribing Practices in Children and Adolescents: Florida Medicaid Initiatives Mary Elizabeth Jones, Pharm BSc, RPh Senior Pharmacist AHCA Pharmacy

More information

Borderline personality disorder: what role for medication?

Borderline personality disorder: what role for medication? Borderline personality disorder: what role for medication? Mike Crawford Imperial College London CNWL NHS Foundation Trust m.crawford@imperial.ac.uk Licensed medication for PD Jane, 34, moderately severe

More information

Adolescent risk-taking

Adolescent risk-taking Adolescent risk-taking OVERVIEW This document provides an overview of the scientific community s current understanding of why adolescents are more likely than children or adults to engage in risk-taking

More information

#CHAIR2016. September 15 17, 2016 The Biltmore Hotel Miami, FL. Sponsored by

#CHAIR2016. September 15 17, 2016 The Biltmore Hotel Miami, FL. Sponsored by #CHAIR2016 September 15 17, 2016 The Biltmore Hotel Miami, FL Sponsored by Pediatric Bipolar Disorder: Diagnosis and Management Karen Dineen Wagner, MD, PhD University of Texas Medical Branch Galveston,

More information

ADHD & PTSD. ADHD Across the Lifespan March 18, 2017 Andrea E. Spencer, MD.

ADHD & PTSD. ADHD Across the Lifespan March 18, 2017 Andrea E. Spencer, MD. ADHD & PTSD ADHD Across the Lifespan March 18, 2017 Andrea E. Spencer, MD Disclosures Neither I nor my partner has a relevant financial relationship with a commercial interest to disclose. Acknowledgments

More information

Donald W. Black, MD. Professor, Program Director, and Vice Chair for Education

Donald W. Black, MD. Professor, Program Director, and Vice Chair for Education Donald W. Black, MD Professor, Program Director, and Vice Chair for Education Department of Psychiatry University of Iowa Carver College of Medicine SUNY Buffalo Psychiatry Grand Rounds May 5, 2017 Funding

More information

Approach to the Patient with Borderline Personality Disorder in Primary Care

Approach to the Patient with Borderline Personality Disorder in Primary Care Approach to the Patient with Borderline Personality Disorder in Primary Care Cerrone Cohen, MD Duke University Departments of Family Medicine & Psychiatry 1 What is Borderline Personality Disorder? 1 What

More information

Neurobiology of Addiction. Jon E. Grant, JD, MD, MPH Professor University of Chicago

Neurobiology of Addiction. Jon E. Grant, JD, MD, MPH Professor University of Chicago Neurobiology of Addiction Jon E. Grant, JD, MD, MPH Professor University of Chicago Disclosure Information I have the following financial relationships to disclose: My research is supported by NIDA, AFSP,

More information

Curriculum Vitae Madeline Harms, Ph.D.

Curriculum Vitae Madeline Harms, Ph.D. Curriculum Vitae Madeline Harms, Ph.D. Child Emotion Lab Waisman Center, rm 399 1500 Highland Ave Madison, WI 53705 Phone: 785-230-7332 (cell) e-mail: mharms3@wisc.edu Education Graduate: Institute of

More information

PRIMARY CARE MANAGEMENT OF OBESITY

PRIMARY CARE MANAGEMENT OF OBESITY Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences PRIMARY CARE MANAGEMENT OF OBESITY LYDIA CHWASTIAK MD, MPH ASSOCIATE PROFESSOR UNIVERSITY OF WASHINGTON DEPARTMENT

More information

BL-1020: First-in-Class GABA-Enhanced Antipsychotic For Schizophrenia

BL-1020: First-in-Class GABA-Enhanced Antipsychotic For Schizophrenia BL-1020: First-in-Class GABA-Enhanced Antipsychotic For Schizophrenia December 2012 Forward Looking Statements This presentation contains "forward-looking statements." These statements include words like

More information

Update on Pediatric Bipolar Disorder

Update on Pediatric Bipolar Disorder Update on Pediatric Bipolar Disorder Benjamin I. Goldstein, MD,, FRCPC Associate Professor Departments of Psychiatry & Pharmacology Sunnybrook Health Sciences Centre University of Toronto Faculty of Medicine

More information

Antipsychotics in Bipolar

Antipsychotics in Bipolar Use of Second-Generation Antipsychotics in Bipolar Disorder: A Practical Guide Flavio Guzman, MD Editor Psychopharmacology Institute This practical guide is an update on the use of second-generation antipsychotics

More information

6/23/2015. Disclosures. Overview. Learning Objectives

6/23/2015. Disclosures. Overview. Learning Objectives Disclosures The speakers have no known or real conflicts of interest to declare 16th Annual Canadian Collaborative Mental Health care Conference June 18-20, 2015 Murli Soni, Bounce Back Program Manager

More information

Treatment of Bipolar Disorder in Youth

Treatment of Bipolar Disorder in Youth Treatment of Bipolar Disorder in Youth Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric Bipolar Disorder Research Program Harvard Medical School Massachusetts General Hospital

More information

Cognitive and neuroimaging findings in pathological gambling

Cognitive and neuroimaging findings in pathological gambling Cognitive and neuroimaging findings in pathological gambling TNU seminar on Pathological Gambling, 2.11.2012 Jakob Heinzle Translational Neuromodeling Unit (TNU), Institute for Biomedical Engineering (IBT),

More information

PEDIATRIC BIPOLAR DISORDER

PEDIATRIC BIPOLAR DISORDER PEDIATRIC BIPOLAR DISORDER Swapna Deshpande, MD Clinical Assistant Professor Associate Training Director, Child/Adolescent Fellowship Program Department of Psychiatry & Behavioral Sciences University of

More information

What can we do to improve the outcomes for all adolescents? Changes to the brain and adolescence-- Structural and functional changes in the brain

What can we do to improve the outcomes for all adolescents? Changes to the brain and adolescence-- Structural and functional changes in the brain The Adolescent Brain-- Implications for the SLP Melissa McGrath, M.A., CCC-SLP Ball State University Indiana Speech Language and Hearing Association- Spring Convention April 15, 2016 State of adolescents

More information

What s New in Psychotropic Prescribing for Children: Trends, Guidelines & Practice

What s New in Psychotropic Prescribing for Children: Trends, Guidelines & Practice 3 rd Annual Challenges & Innovations in Rural Psychiatry Conference What s New in Psychotropic Prescribing for Children: Trends, Guidelines & Practice June 22, 2016 What s New in Psychotropic Prescribing

More information

Medications in Autism: What We Know and Don't Know

Medications in Autism: What We Know and Don't Know Medications in Autism: What We Know and Don't Know Jeremy Veenstra-VanderWeele, M.D. Mortimer D. Sackler, M.D., Associate Professor Center for Autism and the Developing Brain Sackler Institute for Developmental

More information

Comprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula

Comprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula Comprehensive Quick Reference Handout on Pediatric Bipolar Disorder By Jessica Tomasula Official Name Bipolar Disorder; also referred to as Manic Depression Definitions (DSM-IV-TR, 2000) Bipolar I Disorder

More information

Neurocircuitry Of Suicidal Behavior In Adolescents And Young Adults With Bipolar And Major Depressive Disorder

Neurocircuitry Of Suicidal Behavior In Adolescents And Young Adults With Bipolar And Major Depressive Disorder Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2015 Neurocircuitry Of Suicidal Behavior In Adolescents And

More information

Thinking Outside the Box: Prescribing by Synthesis & Integration

Thinking Outside the Box: Prescribing by Synthesis & Integration Thinking Outside the Box: Prescribing by Synthesis & Integration Barbara J. Limandri, DNSc, APRN, BC Linfield College School of Nursing Portland DBT Program AGENDA Neuroanatomy and neurophysiology review

More information

HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D.

HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D. HDSA Annual Convention June 2013 Behavior Issues: Irritability and Depression Peg Nopoulos, M.D. Professor of Psychiatry, Neurology, and Pediatrics University of Iowa, Iowa City, Iowa The information provided

More information

The Neuroscience of Addiction: A mini-review

The Neuroscience of Addiction: A mini-review The Neuroscience of Addiction: A mini-review Jim Morrill, MD, PhD MGH Charlestown HealthCare Center Massachusetts General Hospital Disclosures Neither I nor my spouse/partner has a relevant financial relationship

More information

3/10/14. Executive Functions

3/10/14. Executive Functions Minimize the Madness- Taking the Mystery out of ADHD Medications Class #2 The Executive Function: The Source of ADHD Symptoms Presented by Laurie Dupar, Certified ADHD Coach and Nurse Practitioner Executive

More information

FMRI and Treatment Development for Addictions

FMRI and Treatment Development for Addictions FMRI and Treatment Development for Addictions Marc N. Potenza, M.D., Ph.D. Professor of Psychiatry, Child Study, and Neurobiology Director, Yale Gambling Center of Research Excellence (CORE) Director,

More information

Why gamblers fail to win: evidence from neuroscience

Why gamblers fail to win: evidence from neuroscience Why gamblers fail to win: evidence from neuroscience Anna E. Goudriaan Principal Investigator Arkin Mental Health Academic Medical Center, Department of Psychiatry Universitty of Amsterdam Jellinek Gambling

More information

The Impact of Anxiety-Inducing Distraction on Cognitive Performance: A Combined Brain Imaging and Personality Investigation

The Impact of Anxiety-Inducing Distraction on Cognitive Performance: A Combined Brain Imaging and Personality Investigation The Impact of Anxiety-Inducing Distraction on Cognitive Performance: A Combined Brain Imaging and Personality Investigation Ekaterina Denkova 1, Gloria Wong 2, Sanda Dolcos 3, Keen Sung 1, Lihong Wang

More information

BINGES, BLUNTS AND BRAIN DEVELOPMENT

BINGES, BLUNTS AND BRAIN DEVELOPMENT BINGES, BLUNTS AND BRAIN DEVELOPMENT Why delaying the onset of alcohol and other drug use during adolescence is so important Aaron White, PhD Division of Epidemiology and Prevention Research National Institute

More information

Disclosure Statement. Learning Objectives. Background. Background 4/26/2016

Disclosure Statement. Learning Objectives. Background. Background 4/26/2016 Disclosure Statement Implementation of Education plus Provider- Specific Prescribing Reports and the Effects on Antipsychotic Polypharmacy in Children and Adolescents with Mental Illness in an Outpatient

More information

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents BadgerCare Plus Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice

More information

Severe Mood Dysregulation in Children and Adolescents Research Findings Support Diagnostic Validity of Pediatric Bipolar Disorder

Severe Mood Dysregulation in Children and Adolescents Research Findings Support Diagnostic Validity of Pediatric Bipolar Disorder Severe Mood Dysregulation in Children and Adolescents Research Findings Support Diagnostic Validity of Pediatric Bipolar Disorder Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric

More information

Pediatric Bipolar Disorder: Advances in Diagnosis and Research

Pediatric Bipolar Disorder: Advances in Diagnosis and Research Pediatric Bipolar Disorder: Advances in Diagnosis and Research Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric Bipolar Disorder Research Program Harvard Medical School Massachusetts

More information

Practical Guide to Long-Term Pharmacotherapy in Bipolar Disorder: An Updated Synthesis of Current Clinical Guidelines

Practical Guide to Long-Term Pharmacotherapy in Bipolar Disorder: An Updated Synthesis of Current Clinical Guidelines SECOND-GENERATION ANTIPSYCHOTICS IN BIPOLAR DISORDER Practical Guide to Long-Term Pharmacotherapy in Bipolar Disorder: An Updated Synthesis of Current s Flavio Guzman, MD Editor Psychopharmacology Institute

More information

Pediatric Bipolar Disorder and ADHD

Pediatric Bipolar Disorder and ADHD Pediatric Bipolar Disorder and ADHD Janet Wozniak, M.D. Director, Pediatric Bipolar Disorder Research Program Associate Professor Psychiatry Massachusetts General Hospital Harvard Medical School Disclosures

More information

Basic definition and Classification of Anhedonia. Preclinical and Clinical assessment of anhedonia.

Basic definition and Classification of Anhedonia. Preclinical and Clinical assessment of anhedonia. Basic definition and Classification of Anhedonia. Preclinical and Clinical assessment of anhedonia. Neurobiological basis and pathways involved in anhedonia. Objective characterization and computational

More information

Attention-deficit Hyperactivity Disorder ADHD

Attention-deficit Hyperactivity Disorder ADHD Attention-deficit Hyperactivity Disorder ADHD Jan Buitelaar Radboud University Nijmegen Medical Center Donders Institute for Brain, Cognition and Behavior Department of Cognitive Neuroscience, and Karakter

More information

Gender Sensitive Factors in Girls Delinquency

Gender Sensitive Factors in Girls Delinquency Gender Sensitive Factors in Girls Delinquency Diana Fishbein, Ph.D. Research Triangle Institute Transdisciplinary Behavioral Science Program Shari Miller-Johnson, Ph.D. Duke University Center for Child

More information

6B / Boswell, Grant and Slutske Day 2 August 14, 2008

6B / Boswell, Grant and Slutske Day 2 August 14, 2008 Pharmacological Treatment of Pathological Gambling Jon E. Grant, JD, MD, MPH Associate Professor University of Minnesota School of Medicine Minneapolis, MN Disclosure Information I have the following financial

More information

Disclosure Statement. A Rational Approach to Psychopharmacology. Goals 10/28/2013

Disclosure Statement. A Rational Approach to Psychopharmacology. Goals 10/28/2013 A Rational Approach to Psychopharmacology Disclosure Statement Full time employed physician with MaineGeneral Medical Center in Waterville and Augusta No conflicts of interest to disclose Goals Promote

More information

Psychotropic Medication Management in Children and Adolescents

Psychotropic Medication Management in Children and Adolescents Drug Use Research & Management Program DHS Division of Medical Assistance Programs, 500 Summer Street NE, E35; Salem, OR 97301-1079 Phone 503-947-5220 Fax 503-947-1119 Psychotropic Medication Management

More information

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 4,000 116,000 120M Open access books available International authors and editors Downloads Our

More information

Pro-cognitive strategies in Bipolar Disorder: Challenges and New Directions. Sophia Frangou, MD, PhD, FRCPsych Professor of Psychiatry

Pro-cognitive strategies in Bipolar Disorder: Challenges and New Directions. Sophia Frangou, MD, PhD, FRCPsych Professor of Psychiatry Pro-cognitive strategies in Bipolar Disorder: Challenges and New Directions Sophia Frangou, MD, PhD, FRCPsych Professor of Psychiatry Challenges 1. Conceptual challenges Relationship between cognitive

More information

PSYCHIATRY ALERTS. Conduct Disorder in Girls. Basal Ganglia Morphology and Stimulants in ADHD

PSYCHIATRY ALERTS. Conduct Disorder in Girls. Basal Ganglia Morphology and Stimulants in ADHD Basal Ganglia Morphology in ADHD...37 Conduct Disorder in Girls...37 CHILD& ADOLESCENT PSYCHIATRY ALERTS Histamine, Food Additives, and ADHD...38 Lithium Pharmacokinetics...40 Migraine and Mental Illness...40

More information

Prescribing medications for people with a personality disorder A service evaluation of a community mental health team

Prescribing medications for people with a personality disorder A service evaluation of a community mental health team Prescribing medications for people with a personality disorder A service evaluation of a community mental health team Dr Umama Khan, Consultant Psychiatrist Dr Venkatesh Ballagere, Specialist Registrar

More information

Neuroimaging of ADHD and Executive Functions

Neuroimaging of ADHD and Executive Functions Neuroimaging of ADHD and Executive Functions John Gabrieli Department of Brain and Cognitive Sciences & Martinos Imaging Center at the McGovern Institute for Brain Research, MIT Disclosures Neither I nor

More information

Pediatric Psychopharmacology

Pediatric Psychopharmacology Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders

More information

Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK).

Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK). Paediatric Psychopharmacology. Dr Jalpa Bhuta. MD, DNB, MRCPsych (UK). Childhood pharmacokinetics Children have greater hepatic capacity More glomerular filtration Less fatty tissue Less ability to store

More information

Driving to Distraction

Driving to Distraction Driving to Distraction New Research on the Impact of ADHD and ADHD Medications on Driving performance Daniel J. Cox, Ph.D., A.B.P.P Professor, Departments of Psychiatric and Internal Medicine Director,

More information

Management of Bipolar Depression

Management of Bipolar Depression Management of Bipolar Depression Haresh M. Tharwani, M.D. Associate Clinical Professor Medical Director-DRH & Duke Psychiatry Specialty Clinic of Cary, N.C. Bipolar Disorders (Manic-Depressive illness)

More information

Slide 1. Slide 2. Slide 3. Risperidone Binding Profile. Risperidone Prescribing Facts. Risperidone Prescribing Facts

Slide 1. Slide 2. Slide 3. Risperidone Binding Profile. Risperidone Prescribing Facts. Risperidone Prescribing Facts Slide 1 Risperidone Binding Profile (high affinity for D2 receptors) a 1 antagonist a 2 antagonist Slide 2 Risperidone Prescribing Facts 2 8 mg/day for acute psychosis and bipolar disorder 0.5-2 mg /day

More information

Attention deficit hyperactivity disorder (ADHD), Conduct disorder biological treatments

Attention deficit hyperactivity disorder (ADHD), Conduct disorder biological treatments Attention deficit hyperactivity disorder (ADHD), Conduct disorder biological treatments Professor Alasdair Vance Head, Academic Child Psychiatry Department of Paediatrics University of Melbourne Royal

More information

Neural mechanisms of the cognitive model of depression

Neural mechanisms of the cognitive model of depression Nature Reviews Neuroscience AOP, published online 6 July 2011; doi:10.1038/nrn3027 REVIEWS Neural mechanisms of the cognitive model of depression Seth G. Disner*, Christopher G. Beevers*, Emily A. P. Haigh

More information